Patients taking renin-angiotensin-aldosterone system inhibitor (RAASi) medications for heart failure had significantly lower blood potassium levels when taking patiromer—a drug that helps to prevent the body from absorbing too much potassium—compared with a placebo, in a study presented at the American College of Cardiology’s 71st Annual Scientific Session.
News | Heart Failure
Patiromer Helps Patients Stay on Optimal Heart Failure Therapy
April 8, 2022 – Patients taking renin-angiotensin-aldosterone system inhibitor (RAASi) medications for heart failure had ...
Home April 08, 2022
Home
Patients who received a transcatheter supra-annular self-expanding heart valve had significantly less structural deterioration in the valve after five years compared with similar patients who had the biologic valve inserted surgically.
News | Structural Heart
Rate of Structural Valve Deterioration Lower with TAVR than with SAVR
April 8, 2022 – Patients who received a transcatheter supra-annular self-expanding heart valve had significantly less ...
Home April 08, 2022
Home
The American College of Cardiology’s Global Heart Attack Treatment Initiative (GHATI) reports continuing improvements in quality care delivery for heart attacks in low- and middle-income countries with the use of data collection and localized education around guideline-directed medical therapy, according to data from the program’s second year.
News | STEMI
ACC Program sees Improvement in Global Heart Attack Care

April 7, 2022 – The American College of Cardiology’s Global Heart Attack Treatment Initiative (GHATI) reports continuing ...

Home April 07, 2022
Home
ADAPT-TAVR Trial
News | Structural Heart
No Reduction in Stroke, Mini Strokes, Blood Clotting in the Brain or Changes in Cognitive Function with Edoxaban After TAVR

April 7, 2022 – Patients treated with the blood thinner edoxaban for six months after a heart valve replacement ...

Home April 07, 2022
Home
Tricuspid valve
News | Cardiovascular Clinical Studies
Tricuspid Valve Repair System Shows Promising Results at One-year Follow-up

April 7, 2022 – Patients with tricuspid regurgitation, a common and debilitating form of valvular heart disease, who ...

Home April 07, 2022
Home
Among patients undergoing non-cardiac surgery who were also on blood pressure medications, a multifaceted strategy to try to keep their blood pressure from dropping to a potentially dangerous low level immediately before, during and for up to two days after surgery made no difference in the rates of major cardiovascular events in the 30 days following surgery.
News | Hypertension
Blood Pressure Management Strategy During Surgery Has No Impact on Major Cardiovascular Complications

April 7, 2022 – Among patients undergoing non-cardiac surgery who were also on blood pressure medications, a ...

Home April 07, 2022
Home
While there are effective therapies to reduce the risk of heart disease by lowering low-density lipoprotein (LDL), or “bad” cholesterol, and other lipids, to date there are no approved treatments to lower lipoprotein(a), a lesser-known driver of heart disease risk.
News | Cardiovascular Clinical Studies
SLN360 Markedly Reduces Lipoprotein(a), an Important Cause of Heart Disease

April 7, 2022 – While there are effective therapies to reduce the risk of heart disease by lowering low-density ...

Home April 06, 2022
Home
Final results from the BIO|GUARD-MI study show a 31 percent reduction of MACE in a sub-group analysis of patients with non-ST segment elevation myocardial infarction (NSTEMI).
News | Implantable Cardiac Monitor (ICM)
Insertable Cardiac Monitors (ICM) and Remote Monitoring May Improve Outcomes for Post-Myocardial Infarction Patients, Study Demonstrates
April 6, 2022 – Final results from the BIO|GUARD-MI study show a 31 percent reduction of MACE in a sub-group analysis of ...
Home April 06, 2022
Home
Deaths among hospitalized patients who had both COVID-19 and the most severe type of heart attack were 25% lower in 2021 than in 2020, and no deaths occurred among patients who had been vaccinated against COVID-19, according to data presented at the American College of Cardiology’s 71st Annual Scientific Session.
News | STEMI
In-Hospital Deaths in STEMI Patients With COVID-19 Drop in 2021

April 6, 2022 – Deaths among hospitalized patients who had both COVID-19 and the most severe type of heart attack were ...

Home April 06, 2022
Home
Donisi Health, a MedTech company working to disrupt the readmission cycle of congestive heart failure (CHF) patients, announced results of a clinical study demonstrating the efficacy of its contact-free technology for the detection of pulmonary congestion at home.
News | Heart Failure
Study Demonstrates Efficacy of Contact-Free Tech for Pulmonary Congestion Detection at Home
April 6, 2022 – Donisi Health, a MedTech company working to disrupt the readmission cycle of congestive heart failure ...
Home April 06, 2022
Home
Brigitta Brott, M.D., and Ho-Wook Jun, Ph.D.
News | Stents
NIH Grant to UAB will Fund Study of Safer, More Durable Stents

April 6, 2022 – Narrowed arteries can restrict blood flow to the heart. One treatment is inserting a stent — a small ...

Home April 06, 2022
Home
According to ARRS’ American Journal of Roentgenology (AJR), the 3-T Dixon gradient-recalled echo (GRE) sequence performed higher than the current standard of 1.5-T SSFP for unenhanced coronary MRA, which could help expand clinical adoption of the procedure.
News | Angiography
Dixon GRE Technique Outperforms Clinical Standard for Unenhanced Coronary MRA
April 6, 2022 – According to ARRS’ American Journal of Roentgenology (AJR), the 3-T Dixon gradient-recalled echo (GRE) ...
Home April 06, 2022
Home
Myocarditis (inflammation of the heart muscle) is usually caused by viruses, such as in Covid-19 disease. However, it can also be induced by medication, toxic substances or in the context of a rheumatological disease.
News | Artificial Intelligence
AI Enables Personalized Treatment of Myocarditis
April 6, 2022 – Myocarditis (inflammation of the heart muscle) is usually caused by viruses, such as in Covid-19 disease ...
Home April 06, 2022
Home
Kartik Balachandran
News | Coronavirus (COVID-19)
NIH Awards $437,000 to Study Effects of COVID on Aortic Valve

April 6, 2022 – The National Institute of Health awarded $436,642 to associate professor of biomedical engineering ...

Home April 06, 2022
Home
Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the Aveir single-chamber (VR) leadless pacemaker for the treatment of patients in the U.S. with slow heart rhythms.
News | Pacemakers
Abbott Receives FDA Approval for Aveir VR Leadless Pacemaker System

April 5, 2022 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the Aveir single-chamber ...

Home April 05, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now